[Hereditary cerebral amyloid angiopathies].
Cerebral amyloid angiopathies are defined by the presence of amyloid substance in the walls of cerebral vessels. All amyloid substances have a particular physico-chemical structure, which imparts certain specific staining properties, but the biochemical composition of different amyloid types varies. Different forms of cerebral amyloid angiopathy have been identified, based on the biochemical nature of the protein deposited (e.g. beta-amyloid, cystatin C, transthyretin, gelsolin, amyloid protein Bri, prion protein). Some cerebral amyloid angiopathies are familial; these prompted genetic studies which in turn led to a better understanding of the genes coding for different amyloid proteins. As a group, cerebral amyloid angiopathies have certain neuropathological lesions in common. Infiltration by amyloid substance results in weakening of the small vessel walls and secondary complications responsible for changes such as microinfarcts and miliary haemorrhages in the cerebral cortex, lobar haemorrhages and/or leucoencephalopathy. These changes form the basis of the neurological complications: meningeal and cerebral haemorrhages, transient ischaemic episodes, vascular dementia. However each type of hereditary cerebral amyloid angiopathy has individual clinical and histopathological features reflecting the severity of arterial involvement, the extent of amyloid deposition within or outside the central nervous system, and the association with other neurodegenarative changes.
Gray
F
F
Laboratoire de Neuropathologie, Hôpital Raymond Poincaré, Paris. francoise.gray@rpc.ap-hop-paris.fr
Chrétien
F
F
Keohane
C
C
D000544:Alzheimer Disease / Q000175:diagnosis / Q000473:pathology; D000682:Amyloid / Q000235:genetics / Q000378:metabolism; D028243:Cerebral Amyloid Angiopathy, Familial / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D002536:Cerebral Arteries / Q000473:pathology; D006801:Humans; D009154:Mutation / Q000235:genetics
D000682:Amyloid